News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
758,387 Results
Type
Article (52566)
Company Profile (330)
Press Release (705491)
Section
Business (220850)
Career Advice (2688)
Deals (37343)
Drug Delivery (113)
Drug Development (85060)
Employer Resources (180)
FDA (17193)
Job Trends (16032)
News (370898)
Policy (35335)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (6)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2836)
Academic (1)
Accelerated approval (2)
Adcomms (27)
Allergies (81)
Alliances (54578)
ALS (80)
Alzheimer's disease (1382)
Antibody-drug conjugate (ADC) (117)
Approvals (17161)
Artificial intelligence (241)
Autoimmune disease (11)
Automation (14)
Bankruptcy (371)
Best Places to Work (12275)
BIOSECURE Act (20)
Biosimilars (95)
Biotechnology (231)
Bladder cancer (52)
Brain cancer (24)
Breast cancer (243)
Cancer (1861)
Cardiovascular disease (139)
Career advice (2252)
Career pathing (32)
CAR-T (142)
Cell therapy (412)
Cervical cancer (14)
Clinical research (68295)
Collaboration (747)
Compensation (389)
Complete response letters (21)
COVID-19 (2744)
CRISPR (38)
C-suite (186)
Cystic fibrosis (102)
Data (1740)
Decentralized trials (2)
Denatured (34)
Depression (40)
Diabetes (232)
Diagnostics (6699)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (113)
Drug pricing (108)
Drug shortages (27)
Duchenne muscular dystrophy (67)
Earnings (91127)
Editorial (33)
Employer branding (22)
Employer resources (155)
Events (121370)
Executive appointments (622)
FDA (18183)
Featured Employer (58)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (661)
Gene editing (96)
Generative AI (27)
Gene therapy (288)
GLP-1 (719)
Government (4758)
Grass and pollen (4)
Guidances (44)
Healthcare (20202)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (94)
Indications (24)
Infectious disease (2870)
Inflammatory bowel disease (135)
Inflation Reduction Act (10)
Influenza (45)
Intellectual property (72)
Interviews (458)
IPO (17051)
IRA (45)
Job creations (4221)
Job search strategy (1903)
Kidney cancer (9)
Labor market (27)
Layoffs (491)
Leadership (17)
Legal (8753)
Liver cancer (71)
Lung cancer (271)
Lymphoma (121)
Machine learning (2)
Management (63)
Manufacturing (262)
MASH (59)
Medical device (14204)
Medtech (14209)
Mergers & acquisitions (20698)
Metabolic disorders (616)
Multiple sclerosis (62)
NASH (18)
Neurodegenerative disease (77)
Neuropsychiatric disorders (24)
Neuroscience (1835)
NextGen: Class of 2025 (7170)
Non-profit (4904)
Northern California (2239)
Now hiring (36)
Obesity (337)
Opinion (237)
Ovarian cancer (62)
Pain (74)
Pancreatic cancer (71)
Parkinson's disease (120)
Partnered (18)
Patents (185)
Patient recruitment (80)
Peanut (49)
People (61435)
Pharmaceutical (75)
Pharmacy benefit managers (20)
Phase I (21257)
Phase II (29911)
Phase III (22427)
Pipeline (819)
Podcasts (94)
Policy (113)
Postmarket research (2876)
Preclinical (9201)
Press Release (71)
Prostate cancer (89)
Psychedelics (35)
Radiopharmaceuticals (261)
Rare diseases (362)
Real estate (6566)
Recruiting (67)
Regulatory (23700)
Reports (45)
Research institute (2542)
Resumes & cover letters (441)
Rett syndrome (2)
RNA editing (1)
RSV (40)
Schizophrenia (66)
Series A (119)
Series B (71)
Service/supplier (15)
Sickle cell disease (55)
Southern California (1931)
Special edition (15)
Sponsored (31)
Startups (3941)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (59)
United States (20105)
Vaccines (688)
Venture capitalists (35)
Webinars (13)
Weight loss (244)
Women's health (34)
Worklife (15)
Date
Today (195)
Last 7 days (835)
Last 30 days (3037)
Last 365 days (35917)
2025 (5831)
2024 (36834)
2023 (41733)
2022 (53086)
2021 (57835)
2020 (56714)
2019 (49973)
2018 (37785)
2017 (34814)
2016 (34968)
2015 (41110)
2014 (35204)
2013 (30635)
2012 (32697)
2011 (33063)
2010 (31462)
Location
Africa (930)
Alabama (52)
Alaska (7)
Arizona (226)
Arkansas (13)
Asia (43244)
Australia (7263)
California (5143)
Canada (1780)
China (435)
Colorado (237)
Connecticut (255)
Delaware (116)
Europe (96375)
Florida (752)
Georgia (182)
Idaho (61)
Illinois (505)
India (21)
Indiana (283)
Iowa (7)
Japan (129)
Kansas (104)
Kentucky (26)
Louisiana (8)
Maine (67)
Maryland (810)
Massachusetts (3981)
Michigan (222)
Minnesota (359)
Mississippi (2)
Missouri (76)
Montana (30)
Nebraska (26)
Nevada (55)
New Hampshire (67)
New Jersey (1465)
New Mexico (29)
New York (1466)
North Carolina (958)
North Dakota (8)
Northern California (2239)
Ohio (185)
Oklahoma (14)
Oregon (36)
Pennsylvania (1156)
Puerto Rico (7)
Rhode Island (24)
South America (1324)
South Carolina (13)
South Dakota (1)
Southern California (1931)
Tennessee (85)
Texas (749)
Utah (161)
Virginia (122)
Washington D.C. (58)
Washington State (496)
West Virginia (3)
Wisconsin (50)
758,387 Results for "baxter international inc and technology resources".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers
Last week Exergen Corporation filed a lawsuit against Baxter International Inc. in the United States District Court for the District of Massachusetts.
April 24, 2024
·
1 min read
Press Releases
Baxter Reports Fourth-Quarter and Full-Year 2024 Results
February 20, 2025
·
19 min read
Business
Baxter Reports First-Quarter 2024 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
May 2, 2024
·
31 min read
Press Releases
Baxter Announces CEO Retirement and Appointment of COO
February 3, 2025
·
9 min read
Press Releases
Baxter Declares Quarterly Dividend - February 11, 2025
February 12, 2025
·
1 min read
Deals
Baxter Declares Quarterly Dividend - May 7, 2024
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock.
May 7, 2024
·
1 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
BioMidwest
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
Baxter International Inc. announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S. “These launches demonstrate Baxter’s focus on differentiated products that address unmet patient needs in key therapeutic areas, including anti-infective and anti-hypotensive medications,” said Alok Sonig, executive vice president and group president, Pharmaceuticals, at Baxter.
April 11, 2024
·
19 min read
FDA
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates.
May 13, 2024
·
8 min read
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
Spectral Medical Inc. is pleased to announce an extension to its supply and distribution agreement with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc., originally entered into in February 2020.
February 21, 2024
·
5 min read
1 of 75,839
Next